Journal
ANNALS OF BIOMEDICAL ENGINEERING
Volume 51, Issue 4, Pages 806-819Publisher
SPRINGER
DOI: 10.1007/s10439-022-03093-x
Keywords
Thoracic aortic aneurysm; Elastase; Elastin; Biomechanics
Categories
Ask authors/readers for more resources
This study found that pentagalloyl glucose (PGG) may be a pharmaceutical option to stabilize elastic fibers in thoracic aortic aneurysm (TAA). The results suggest that PGG treatment can prevent and restore the mechanical and structural changes caused by elastic fiber degradation in TAA.
Thoracic aortic aneurysm (TAA) is characterized by dilation of the aorta that can lead to dissection or rupture. Degradation of elastic fibers is a consistent histopathological feature of TAA that likely contributes to disease progression. Pentagalloyl glucose (PGG) shows promise for stabilizing elastic fibers in abdominal aortic aneurysms, but its efficacy and mechanical effects in the thoracic aorta are unknown. We simulated TAAs using elastase (ELA) to degrade elastic fibers in the mouse ascending aorta and determined the preventative and restorative potential of PGG. Biaxial mechanical tests, constitutive model fitting, and multiphoton imaging were performed on untreated (UNT), PGG, ELA, PGG + ELA, and ELA + PGG treated aortas. PGG treatment alone does not significantly alter mechanical properties or wall structure compared to UNT. ELA treatment alone causes an increase in the unloaded diameter and length, decreased compliance, significant changes in the material constants, and separation of the outer layers of the aortic wall compared to UNT. PGG treatment before or after ELA ameliorates the mechanical and structural changes associated with elastic fiber degradation, with preventative PGG treatment being most effective. These results suggest that PGG is a potential pharmaceutical option to stabilize elastic fibers in TAA.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available